Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19

被引:4
|
作者
Lee, Tze Yan [1 ]
Lim, Wai Feng [2 ]
Ang, Geik Yong [3 ]
Yu, Choo Yee [4 ]
机构
[1] Perdana Univ, Sch Liberal Arts Sci & Technol PUScLST, Kuala Lumpur 50490, Malaysia
[2] Sunway Med Ctr, Bandar Sunway, Subang Jaya 47500, Malaysia
[3] Univ Teknol MARA, Fac Sports Sci & Recreat, Shah Alam 40450, Malaysia
[4] Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Biomol, Serdang 43400, Malaysia
来源
LIFE-BASEL | 2023年 / 13卷 / 08期
关键词
COVID-19; endemic; BA.5; XBB; subvariants; VOI; Malaysia; Omicron; waves; VUM;
D O I
10.3390/life13081644
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
On 5 May 2023, WHO declared the end of coronavirus disease 2019 (COVID-19) as a public health emergency of international concern. However, the risk of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants causing rapid and high surges in cases and deaths remained. In Malaysia, five COVID-19 waves during the pandemic phase were well characterized, but similar studies focusing on the endemic phase were lacking. Hence, we retrieved 14,965 SARS-CoV-2 genomic sequences from the GISAID EpiCoV database for clade, lineage, and phylogenetic analysis in order to provide an insight into the population dynamics of SARS-CoV-2 that circulated in Malaysia from June 2022 to April 2023. The dominance of the Omicron variants was observed, and two new waves of infections driven by BA.5.2 and XBB.1, respectively, were detected. Data as of April 2023 also pointed to a possible eighth wave driven by XBB.1.9. Although new variants associated with higher transmissibility were behind the multiple surges, these subsequent waves had lower intensities as compared to the fourth and fifth waves. The on-going circulation and evolution of SARS-CoV-2 mean that COVID-19 still poses a serious threat, necessitating active genomic surveillance for early warning of potential new variants of concern.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] SARS-CoV-2: The Monster Causes COVID-19
    Song, Chang
    Li, Zesong
    Li, Chen
    Huang, Meiying
    Liu, Jianhong
    Fang, Qiuping
    Cao, Zitong
    Zhang, Lin
    Gao, Pengbo
    Nie, Wendi
    Luo, Xueyao
    Kang, Jianhao
    Xie, Shimin
    Lyu, Jianxin
    Zhu, Xiao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [32] SARS-CoV-2 (COVID-19) superspreader events
    Majra, Dasha
    Benson, Jayme
    Pitts, Jennifer
    Stebbing, Justin
    JOURNAL OF INFECTION, 2021, 82 (01) : 36 - 40
  • [33] COVID-19, SARS-CoV-2, and Export Controls
    Millett, Piers
    Rutten, Paul
    HEALTH SECURITY, 2020, 18 (04) : 329 - 334
  • [34] SARS-CoV-2 (COVID-19) and the Endocrine System
    Lundholm, Michelle D.
    Poku, Caroline
    Emanuele, Nicholas
    Emanuele, Mary Ann
    Lopez, Norma
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (11) : 1 - 13
  • [35] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [36] Decoding Covid-19 with the SARS-CoV-2 Genome
    Phoebe Ellis
    Ferenc Somogyvári
    Dezső P. Virok
    Michela Noseda
    Gary R. McLean
    Current Genetic Medicine Reports, 2021, 9 : 1 - 12
  • [37] One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    Al-Jamal, Ola
    Albatesh, Dana
    Boughattas, Sonia
    Ahmed, Ayeda A.
    Bensaad, Meryem
    Younuskunju, Shameem
    Mohamoud, Yasmin A.
    Al Badr, Mashael
    Mohamed, Abdalla A.
    El-Kahlout, Reham A.
    Al-Hamad, Tasneem
    Elgakhlab, Dina
    Al-Kuwari, Fatima H.
    Saad, Chadi
    Jeremijenko, Andrew
    Al-Khal, Abdullatif
    Al-Maslamani, Muna A.
    Bertollini, Roberto
    Al-Kuwari, Einas A.
    Al-Romaihi, Hamad E.
    Al-Marri, Salih
    Al-Thani, Mohammed
    Badji, Radja M.
    Mbarek, Hamdi
    Al-Sarraj, Yasser
    Malek, Joel A.
    Ismail, Said I.
    Abu-Raddad, Laith J.
    Coyle, Peter, V
    Al Thani, Asmaa A.
    Yassine, Hadi M.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [38] Effectiveness of COVID-19 Vaccines and Antiviral Therapies in the Era of SARS-CoV-2 Variants
    Unuvar, Gamze Kalin
    Rello, Jordi
    Alp, Emine
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2023, 45 (01): : 1 - 7
  • [39] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Piasecki, Egbert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (06)
  • [40] SARS-CoV-2/COVID-19: a primer for cardiologists
    de Vries, A. A. F.
    NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 366 - 383